SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute

  • Indication Has Been Granted FDA Breakthrough Device Designation for Potential PMA Filing Indication Has Been Granted FDA Breakthrough Device Designation for Potential PMA Filing